Patient-Focused Drug Development: Engaging Patients to Spark Real Change

preview_player
Показать описание
Moderated by Dana-Farber’s President & CEO, Laurie H. Glimcher, MD, Giovanni Caforio, MD, George D. Demetri, MD, FACP, FASCO, Katherine A. Janeway, MD, MMSc, and John Maraganore, PhD, discuss how patient-focused drug development can accelerate new lifesaving medicines.
Рекомендации по теме